Skip to main content
Clinical Trials/CTRI/2021/09/036474
CTRI/2021/09/036474
Not applicable
Phase 2

ââ?¬Å?Clinical study for the evaluation of efficacy and safety of Unani formulation in the management of Cirrhosis of Liverââ?¬?

Deptt of Moalajat School of Unani Medical Education and Research Jamia Hamdard University0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Deptt of Moalajat School of Unani Medical Education and Research Jamia Hamdard University
Status
Not applicable
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional

Investigators

Sponsor
Deptt of Moalajat School of Unani Medical Education and Research Jamia Hamdard University

Eligibility Criteria

Inclusion Criteria

  • Radiological ( Elastography: Metavir score ââ?°Â¥ f4(i.e. more than 12kPa) evidence of liver cirrhosis
  • Child\-turcotte\-Pugh Score A and B

Exclusion Criteria

  • Pregnant women and lactating mothers
  • Mentally retarded patients
  • Patients who failed to give informed consent
  • Patient with Hepatic Encephalopathy
  • Patients with comorbid heart and kidney disease
  • History of active bleeding
  • Severe bacterial infection
  • History of malignancy
  • Patient whose CHILD PUGH score lies in category C
  • Uncontrolled Diabetes Mellitus

Outcomes

Primary Outcomes

Not specified

Similar Trials